icddr,b senior scientist Dr K Zaman with his collaborative team from the Centre for Disease Control and Prevention (CDC) have won the Charles C. Shepard Science Award for the second time! Dr Zaman’s research findings on immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response, published in the
-
-
Many children not receiving timely immunisation in Bangladesh
Immunisation is one of the most successful and cost-effective means of saving lives. It is a simple and effective measure to protect children (and adults) from serious diseases, giving them the best start to a healthy future. Additionally, not only does immunisation protect the individual, but also greatly benefits the wider community by minimising the
-
What is the financial toll of common childhood illness?
In Bangladesh, training experts to determine what a bout of diarrhoea, measles, or pneumonia truly costs – and better evaluate investments in vaccines By Md. Jasim Uddin While vaccines are widely regarded as one of the most cost-effective public health interventions we still lack evidence on the broader economic impact of vaccines, including the costs
-
Closing the gap on vaccine efficacy in the ‘global south’
Vaccines and antibiotics occupy a privileged position in the history of medicine. They are humanity’s “magic bullets” — categories of intervention so effective and easy to deliver that they have the capacity to single-handedly eradicate entire diseases from human history. But just as the heady utopia of an antibiotic age has given way to the
-
Bringing rotavirus vaccines to Bangladesh
Diseases like cholera and smallpox have become widely known cultural symbols for human suffering and medical progress. The same can hardly be said for rotavirus – outside of doctors and diarrhoeal disease specialists, the word ‘rotavirus’ has failed to find a foothold in everyday speech. Despite this, rotavirus is currently the most common cause of
